Skip to content
Sign in

LGHT · BATS · ETF

Langar Global HealthTech ETF (LGHT) Price, Holdings & Fees

$405.52+0.41%+$1.65End-of-day price as of Oct 9, 2026

Langar Global HealthTech ETF (LGHT) closed at $405.52 on Oct 9, 2026, up 0.41% from the previous close of $403.87.

Share price, past year

1Y +0.95%

52-week range $336.55 – $405.52. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$405.52
Sep 30, 2026$403.29
Aug 31, 2026$363.92
Jul 31, 2026$369.79
Jun 30, 2026$351.33
May 29, 2026$366.36
Apr 30, 2026$361.90
Mar 31, 2026$346.35
Feb 27, 2026$389.61
Jan 30, 2026$364.68
Dec 31, 2025$366.26
Nov 28, 2025$367.82
Oct 31, 2025$375.62

Key statistics

Expense ratio
0.85%
as of Apr 30, 2026
Net assets
$2.5M
as of Jun 30, 2026
Holdings
29
as of Jun 30, 2026
52-week range
$336.55 – $405.52

Langar Global HealthTech ETF's expense ratio is 0.85%: $85.00 a year on $10,000 invested.

Holdings

Langar Global HealthTech ETF held 29 investments worth $2.47M as of Jun 30, 2026. Its largest holding was UMB MONEY MARKET, at 16.83% of the fund.

Langar Global HealthTech ETF largest holdings by share of net assets
#Holding% of fundValue
1UMB MONEY MARKET16.83%$416.34K
2Intuitive Surgical I9.92%$245.37K
3ResMed Inc9.11%$225.28K
4Moderna Inc7.98%$197.41K
5Veeva Systems Inc5.60%$138.43K
6GE HealthCare5.41%$133.84K
7IQVIA Holdings Inc4.98%$123.27K
8Koninklijke Philips4.62%$114.25K
9Insulet Corp4.44%$109.77K
10DEXCOM INC COM4.01%$99.21K
11Zimmer Biomet Holdin3.75%$92.81K
12Siemens Healthineers3.19%$78.81K
13BioNTech SE2.88%$71.37K
14Align Technology Inc2.72%$67.30K
15Sonova Holding AG2.61%$64.58K
16iRhythm Holdings2.39%$59.12K
17Alignment Healthcare1.88%$46.43K
18Privia Health Group1.63%$40.34K
19Doximity Inc1.62%$40.11K
20Alkermes PLC1.42%$35.10K
21Progyny Inc0.64%$15.89K
22PROCEPT BioRobotics0.59%$14.47K
23Omnicell Inc0.45%$11.25K
24Teladoc Inc0.36%$8.92K
25LifeStance Health Gr0.28%$6.91K

Top 25 of 29 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.

What the fund owns

Langar Global HealthTech ETF holdings by asset type
Asset type% of fund
Stocks83.19%
Cash and short-term investments16.83%
Langar Global HealthTech ETF holdings by country, largest 5
Country% of fund
United States85.30%
Germany6.07%
Netherlands4.62%
Switzerland2.61%
Ireland1.42%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jun 30, 2026, Langar Global HealthTech ETF's total return was −1.80%, as reported to the SEC.

Langar Global HealthTech ETF monthly total returns
MonthTotal return
Jun 30, 2026+4.28%
May 31, 2026−0.79%
Apr 30, 2026−5.08%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Langar Global HealthTech ETF
Ticker
LGHT
Exchange
BATS
Fund type
ETF
Trust
Spinnaker ETF Series
SEC series ID
S000082910
SEC CIK
0001484018
Fractional shares
No

Recent SEC filings

Shareholder reports and prospectuses are filed by Spinnaker ETF Series, the trust behind Langar Global HealthTech ETF, and cover all of its funds.

Frequently asked questions

What is LGHT's price?

Langar Global HealthTech ETF (LGHT) closed at $405.52 on Oct 9, 2026, up 0.41% from the previous close of $403.87.

What is LGHT's expense ratio?

Langar Global HealthTech ETF's expense ratio is 0.85%: $85.00 a year on $10,000 invested.

What does LGHT hold?

Langar Global HealthTech ETF held 29 investments worth $2.47M as of Jun 30, 2026. Its largest holding was UMB MONEY MARKET, at 16.83% of the fund. Its five largest holdings were UMB MONEY MARKET, Intuitive Surgical I, ResMed Inc, Moderna Inc, Veeva Systems Inc.

How has LGHT performed?

Over the 3 months to Jun 30, 2026, Langar Global HealthTech ETF's total return was −1.80%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Apr 30, 2026. Prices are generated sample data for development. Data sources and disclosures